Accessibility Menu
Nova Eye Medical logo

Nova Eye Medical(OTC) ELXMF

Market Cap$4.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-98%
5 Year-94%
1 Year-86%
1 Month+653%
$0.01
+0.00%
+0.00Today
Nova Eye Medical last closing stock price
MetricPriceDate
Last closeUSD 0.012026-04-15
Nova Eye Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+652.89%USD 0.002025-12-15
1 month+652.89%USD 0.002025-12-15
3 month+652.89%USD 0.002025-12-15
Year to date+652.89%USD 0.002025-12-15
1 year-85.69%USD 0.102024-02-28
3 year-92.31%USD 0.192023-04-04
5 year-93.64%USD 0.232021-04-13
Since inception-98.09%USD 0.752007-10-17

Nova Eye Medical Financials at a Glance

Market Cap

$4.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$64.10M

Net Income (TTM)

-A$13.39M

EPS (TTM)

-$0.01

P/E Ratio

-1.42

Dividend

$0.00

Beta (Volatility)

26.45 (High)

Price

$0.01

Volume

5,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

Mar 2, 2027

ELXMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nova Eye Medical

Nova Eye Medical Limited is an innovative company focused on developing and commercializing surgical solutions for eye conditions, particularly glaucoma. Established in 1985 and headquartered in Kent Town, Australia, the company has a strong international presence, operating in key markets including the United States, Europe, and Asia Pacific.

Products and Services
  • iTrack surgical system for managing intraocular pressure in glaucoma patients
  • Molteno3 drainage device for severe glaucoma cases
  • 2RT laser technology for treating age-related macular degeneration
Growth Outlook
  • Recent quarterly revenue reached AUD 16.7 million, indicating strong market demand
  • Gross profit margin improved to 70.1% in the latest quarter
  • Expansion into new international markets is underway, enhancing growth potential
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 63.5 million reflects consistent performance
  • Operating income margin improved, reducing losses compared to previous periods
  • Current ratio of 1.85 indicates strong liquidity position
Nova Eye Medical Limited is positioned to capitalize on the growing demand for advanced eye care solutions. The company's innovative product offerings, particularly in glaucoma management, are supported by a solid financial foundation. Recent improvements in gross profit margins and revenue growth highlight the effectiveness of its strategic initiatives. With ongoing expansion efforts and a focus on research and development, Nova Eye Medical Limited presents a compelling opportunity for investors interested in the healthcare sector.
AI Generated • Aug 23, 2026

Industry

Healthcare Equipment and Supplies

CEO

Thomas Spurling

Headquarters

Kent Town, SA 5067, AU

ELXMF Financials

Key Financial Metrics (TTM)

Gross Margin

71.74%

Operating Margin

-12.55%

Net Income Margin

-12.43%

Return on Equity

-28.79%

Return on Capital

-26.25%

Return on Assets

-20.07%

Earnings Yield

-70.42%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

284.88M

Volume

5.00K

Avg. Volume

0

Financials (TTM)

Gross Profit

A$43.88M

Operating Income

-A$8.88M

EBITDA

-A$8.93M

Operating Cash Flow

-A$9.27M

Capital Expenditure

-A$532.81K

Free Cash Flow

-A$9.80M

Cash & ST Invst.

A$962.65K

Total Debt

A$2.39M

Nova Eye Medical Performance Analysis

Nova Eye Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 11,452,79418.0%
20242024-06-30AUD 15,286,62233.5%
20252025-06-30AUD 18,954,21624.0%
20262026-06-30AUD 23,625,32424.6%
Nova Eye Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-2.0%
Q42025-06-3026.4%
Q22025-12-312.2%
Q42026-06-308.5%
Nova Eye Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.0675.4%
20242024-06-30AUD -0.03-56.1%
20252025-06-30AUD -0.02-16.0%
20262026-06-30AUD -0.01-56.5%
Nova Eye Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-62.1%
Q42025-06-3041.3%
Q22025-12-3114.5%
Q42026-06-3070.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$18.13M

+37.5%

Gross Profit

A$13.28M

+17.9%

Gross Margin

73.23%

N/A

Market Cap

$4.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$13.54K

N/A

Employees

301

N/A

Net Income

-A$966.64K

+69.5%

EBITDA

A$154.78K

+110.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$962.65K

-84.3%

Total Debt

A$2.39M

-28.6%

Accounts Receivable

A$5.10M

+25.0%

Inventory

A$3.24M

-24.4%

Long Term Debt

A$1.78M

-37.9%

Short Term Debt

A$610.14K

+27.1%

Return on Assets

-20.07%

N/A

Return on Invested Capital

-27.24%

N/A

Free Cash Flow

-A$942.68K

+74.9%

Operating Cash Flow

-A$844.81K

+77.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AHGIFAlternate Health Corp.
$0.00+0.00%
WOWUWOWI, Inc.
$0.00-50.00%
IPDQFImpediMed Limited
$0.00+0.00%
PYNKFPerimeter Medical Imaging AI, Inc.
$0.21+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$100.83+0.05%
NVDANvidia
$228.85-0.01%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$44.27-0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.48+0.04%

Questions About ELXMF

What is the current price of Nova Eye Medical?

Nova Eye Medical is trading at $0.01 per share.

What is the 52-week range for Nova Eye Medical?

Over the past 52 weeks, Nova Eye Medical has traded between $0.00 and $0.10.

How much debt does Nova Eye Medical have?

As of the most recent reporting period, Nova Eye Medical reported total debt of A$1.66M.

How much cash does Nova Eye Medical have on hand?

Nova Eye Medical reported A$667.86K in cash and cash equivalents in its most recent financial results.

What is Nova Eye Medical’s dividend yield?

Nova Eye Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.